Methacrylic Acid

Methacrylic Acid

SCHEMBL1230397

C=C(C)C(=O)[O-].C=C(C)C(=O)[O-].CC(C)[O-].[Al+3]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.42
CA1 P00915 3/20 0.39
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.36
ALDH1A1 P00352 1/20 0.33
CA2 P00918 1/20 0.32
FAHD1 Q6P587 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL1230669 1.00 CA4 (0.42) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL1230724 0.94 CA4 (0.42) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL1230685 0.94 CA4 (0.42) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL1230756 0.94 CA4 (0.42) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL1228695 0.94 CA4 (0.42) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL135320 0.94 CA4 (0.42) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL1230880 0.94 CA4 (0.42) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL4612859 0.94 CA4 (0.42) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL8024958 0.88 CA4 (0.47) CA4CA1TDP1TSHRALDH1A1
Methacrylic Acid SCHEMBL134295 0.87 CA4 (0.53) CA4CA1TDP1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1746134-B1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS KANEKA CORP (JP) 2019-09-04 EP disclosed
EP-1746135-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2019-05-29 EP disclosed
CN-101778885-B Curable compositions composed of silanes with two hydrolyzable groups HENKEL AG & CO KGAA 2013-07-10 CN disclosed
US-7973108-B2 Curable composition KANEKA CORPORATION (JP) 2011-07-05 US disclosed
US-7910681-B2 Curable composition having improved adhesion KANEKA CORPORATION (JP) 2011-03-22 US disclosed
US-7893170-B2 Curable composition having improved curability and adhesion KANEKA CORPORATION (JP) 2011-02-22 US disclosed
CN-101778885-A Curable compositions composed of silanes with two hydrolyzable groups HENKEL AG & CO KGAA 2010-07-14 CN disclosed
US-20080319152-A1 Curable Composition KANEKA CORPORATION (JP) 2008-12-25 US disclosed
US-20080194773-A1 Polysiloxane from silanetriol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives KANEKA CORPORATION (JP) 2008-08-14 US disclosed
US-20080076878-A1 Organic polymer having a silane tiol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives KANEKA CORPORATION (JP) 2008-03-27 US disclosed
EP-1746134-A1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746133-A1 CURABLE COMPOSITION IMPROVED IN ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746135-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2007-01-24 EP disclosed